Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Glatiramer

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    $ API Ref.Price (USD/KG) : 176,246Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    New data relating to the safety of treatment with COPAXONE® (glatiramer acetate)
    New data relating to the safety of treatment with COPAXONE® (glatiramer acetate)

    23 Jun 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210622006172/fr

    BUSINESSWIRE
    23 Jun 2021
    Share Share
    New safety data on the treatment of breastfeeding mothers with COPAXONE
    New safety data on the treatment of breastfeeding mothers with COPAXONE

    23 Jun 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210622005811/de

    BUSINESSWIRE
    23 Jun 2021
    Share Share
    Copycats wanted: Pfizer, AZ and more under threat as China solicits generics
    Copycats wanted: Pfizer, AZ and more under threat as China solicits generics

    21 Jun 2019

    // Angus Liu FIERCE PHARMA

    https://www.fiercepharma.com/pharma-asia/foreign-drugmakers-under-threat-as-china-rolls-out-drug-list-to-boost-generic

    Angus Liu FIERCE PHARMA
    21 Jun 2019
    Share Share
    Copaxone Generics: Who Will Win First Filer Exclusivity
    Copaxone Generics: Who Will Win First Filer Exclusivity

    25 May 2017

    // Zachary Brennan RAPS

    http://raps.org/Regulatory-Focus/News/2017/05/25/27667/Copaxone-Generics-Who-Will-Win-First-Filer-Exclusivity/?utm_source=Email&utm_medium=Informz&utm_campaign=Informz-Emails

    Zachary Brennan RAPS
    25 May 2017
    Share Share
    Teva sees higher active pharmaceutical ingredient sales in 2016
    Teva sees higher active pharmaceutical ingredient sales in 2016

    15 Feb 2017

    //  Gareth MacDonald IN PHARMATECHNOLOGIST

    http://www.in-pharmatechnologist.com/Ingredients/Teva-sees-higher-active-pharmaceutical-ingredient-sales-in-2016

     Gareth MacDonald IN PHARMATECHNOLOGIST
    15 Feb 2017
    Share Share
    U.S. Supreme Court Ruling on Copaxone Triggers Questions in Generics-Minded India
    U.S. Supreme Court Ruling on Copaxone Triggers Questions in Generics-Minded India

    23 Jan 2015

    // EJ Lane FIERCE PHARMA

    http://www.fiercepharma.com/story/us-supreme-court-ruling-copaxone-triggers-questions-generics-minded-india/2015-01-22

    EJ Lane FIERCE PHARMA
    23 Jan 2015
    Share Share